期刊文献+

右旋美托咪定联合纤维支气管镜在巨大甲状腺肿所致困难气道气管插管中的应用 被引量:1

Application of dexmedetomidine combined with fibreoptic bronchoscope for tracheal intubation in difficult airways caused by huge goiter
下载PDF
导出
摘要 目的:探讨在巨大甲状腺肿所致的困难气道中应用右旋美托咪定联合纤维支气管镜进行气管插管的有效性。方法:选择巨大甲状腺肿致气管受压移位或变形患者30例,采用计算机随机分为右旋美托咪定组(n=15)和丙泊酚组(n=15)。右旋美托咪定组先给予负荷剂量右旋美托咪定1.0μg·kg^-1,输注超过10 min后以0.4μg·kg^-1·h^-1持续泵人。丙泊酚组先缓慢给予丙泊酚2.0 mg·kg^-1,后以5-8 mg·kg^-1·h^-1持续泵人。对插管条件进行评估分级;观察患者在插管过程中的反应,如咳嗽分级和患者插管时的舒适度;记录麻醉前(T0)、Rassay评分为4时(T1)、气管插管时(T2)、插管后1 min(T3)及插管后3 min(T4)5个时间点的心率和血压的变化;记录阿托品和多巴胺的用量以及低氧血症和呼吸抑制等。结果:2组均成功完成纤维支气管镜下气管插管。右旋美托咪定组患者在插管过程中保持良好的自主呼吸,无气道梗阻发生,均能按照指令配合气管插管。丙泊酚组有6例(40.0%)患者出现呼吸道梗阻,11例(73.3%)不能按指令配合气管插管,2组比较差异有统计学意义(P〈0.05)。右旋美托咪定组有12例声门开放,3例声门活动;丙泊酚组有7例声门开放,6例声门活动;右旋美托咪定组较丙泊酚组提供较好的插管条件(P〈0.05)。在整个插管过程中没有反应或只是轻微的面部表情者,右旋美托咪定组有12例,丙泊酚组有8例,2组比较差异有统计学意义(P〈0.05)。右旋美托咪定组患者在T1和T2时刻心率下降更为明显。插管后T3、T4时刻2组患者心率均加快,但右旋美托咪定组患者心率加快不显著,与丙泊酚组比较差异有统计学意义(P〈0.05)。在插管过程中右旋美托咪定组未出现低氧血症和气道梗阻,而丙泊酚组3例出现低氧血症,6例出现气道梗阻。结论:在处理巨大甲状腺肿所致的困难气道时,与丙泊酚比较,右旋美托咪定耐受性好,患者呼吸通畅,插管时血流动力学稳定。 Objective To study the effectiveness of dexmedetomidine combined with fibreoptic bronchoscope for tracheal intubation in difficult airways caused by huge goiter.Methods Thirty patients with anticipated difficult airways caused by huge goiter were enrolled and randomly divided into dexmedetomidine group(n=15) and propofol group(n=15).The patients in dexmedetomidine group received a loading dose of dexmedetomidine(1.0 μg·kg^-1,infused over 10 min,then pumped at continuous rate of 0.4 μg·kg^-1·h^- 1.The patients in propofol group received a loading dose of 2.0 mg·kg^-1and pumped at continuous rate of 5-8 mg·kg^-1·h^- 1.The intubating conditions were graded by a scoring system;the reactions to intubation such as coughing and patient tolerance were observed;the heart rates and mean arterial blood pressures(MABP) at different time points of baseline(T0),Rassay score 4(T1),intubating(T2),1 min after intubation(T3) and 3 min after intubation(T4) were recorded;adverse events and haemodynamic support were observed.Results All the patients in two groups were performed successfully with fibreoptic intubation.The patients in dexmedetomidine group could keep better spontaneous breathing without respiratory depression,and were able to command and cooperate tracheal intubation,while in propofol group 11 patients(73.3%) could not cooperate tracheal intubation(P〈0.05).With respect to intubation scores in propofol group,there were 7 cases of vocal cord opening and 3 cases of vocal cord movement;while in dexmedetomidine group,there were 12 cases in vocal cord opening and 3 cases in vocal cord moving.Compared with propofol group,the patients in dexmedetomidine group had more favorable intubation scores of vocal cord movement(P〈0.05).With respect to no reaction or slight grimacing of reaction to intubation comfort score,there were 8 cases in propofol group and 12 cases in dexmedetomidine group,and there was significant difference(P〈0.05).The patients in dexmedetomidine group experienced fewer airway events and less heart rate response to intubation than those in propofol group(P〈0.05).Conclusion Compared with propofol in management of difficult airways caused by huge goiter,dexmedetomidine has better tolerance,and preserves a patient airway,and has more stable haemodynamic response to intubation.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2012年第2期328-332,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省卫生厅科研基金资助课题(2008Z017)
关键词 右旋美托咪定 困难气道 巨大甲状腺肿 丙泊酚 纤维支气管镜 dexmedetomidine difficult airway huge goiter propofol fibreoptic bronchoscope
  • 相关文献

参考文献13

  • 1李民,张利萍,吴新民.右美托咪啶在临床麻醉中应用的研究进展[J].中国临床药理学杂志,2007,23(6):466-470. 被引量:483
  • 2Maroof M,Khan RM,Jain D,et al.Dexmedetomidine is auseful adjunct for awake intubation[J].Canad J Anaesth,2005,52(3):776-777.
  • 3Ramsey MA,Luterman DL.Dexmedetomidine as a totalintravenous anesthestic agent[J].Anesthesiology,2004,101(3):787-790.
  • 4Moore TA,Markert JM,Knowlton RC.Dexmedetomidine asrescue drug during awake craniotomy for cortical motor mappingand tumor resection[J].Anesth Analg,2006,103(6):1556-1558.
  • 5Abdelmalak B,Makary L,Hoban J,et al.Dexmedetomidineas sole sedative for awake intubation in management of thecritical airway[J].J Clin Anesth,2007,19(2):370-373.
  • 6Bergese SD,Khabiri B,Roberts WD,et al.Dexmedetomidine for conscious sedation in difficult awakefiberoptic intubation cases[J].J Clin Anesth,2007,19(1):141-144.
  • 7Tsai CJ,Chu KS,Chen TI,et al.A comparison of theeffectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotrachealintubation[J].Anaesthesia,2010,65(3):254-259.
  • 8Lallo A,Billard V,Bourgain JL.A comparison of propofoland remifentanil target controlled infusions to facilitatefiberoptic nasotracheal intubation[J].Anesth Analg,2009,108(3):852-857.
  • 9Ard J,Doyle W,Bekker A.Dexmedetomidine in awakecraniotomy:A technical note[J].Surg Neurol,2005,63(1):114-117.
  • 10Rozet I,Souter MJ,Domino K,et al.Dexmedetomidinesedation for awake craniotomies[J].Anesthesiology,2004,101(3):375-376.

二级参考文献39

  • 1[1]Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists:their pharmacology and therapeutic role[J].Anesthesia,1999;54:146-165.
  • 2[2]Kamibayashi T,Maze M.Clinical uses of alpha 2-adrenergic agonists[J].Anesthesiology,2000;93:1345-1350.
  • 3[3]Calzada BC,De Artinano AA.[alpha]2-Adrenoreceptor subtypes[J].Pharmacol Res,2001;44:195-208.
  • 4[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
  • 5[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
  • 6[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
  • 7[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
  • 8[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.
  • 9[9]Ebert TJ,Hall JE,Barney JA,et al.The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000;93:382-394.
  • 10[10]Ramsey MA,Luterman DL.Dexmedetomidine as a total intravenous anesthestic agent[J].Anesthesiology,2004;101:787-781.

共引文献482

同被引文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部